C. Nocent-Ejnaini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
C. Nocent-Ejnaini has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Alain Bernady
Toki-Eder Centre Médical Cardio-Respiratoire, Cambo-les-Bains, France
1 shared publication Annaig Ozier
Department of Pulmonology, Saint Augustin Clinic, Bordeaux, France
1 shared publication- Chantal Raherison
Université de Bordeaux, INSERM UMR 1219, Epicene Team, Bordeaux, France
1 shared publication - Cyrille Hoarau
Laboratoire Inserm UMR1327 ISCHEMIA, Tours, France; Department of Allergy and Clinical Immunology, CHRU de Tours, Tours, France
1 shared publication - Dorian Hassoun
Nantes Université, CHU Nantes, Functional Exploration Department, CNRS, INSERM, l'institut du thorax, F-44000 Nantes, France
1 shared publication - El Hassane Ouaalaya
High Institute of Nursing Professions and Health Techniques (ISPITS), Agadir University, Agadir, Morocco
1 shared publication
Latest Publications
- Open Access
- 1 March 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-13
Sex Differences and Survival Among COPD Patients in France: The Palomb Cohort
Purpose: Previous studies suggest that the clinical presentation of chronic obstructive pulmonary disease (COPD) is different between men and women. The aim of this study was to investigate sex-related differences and survival among COPD patients. Patients and Methods: Multicentric prospective real-life cohort. COPD patients (post-bronchodilator FEV1/FVC < 0.7) of any stages of airway obstruction recruited since January 2014 by pulmonologists. Stratified logistic regression models assessed to identify the determinants of dyspnea, exacerbations, ABE classification and all-cause mortality by sex. Kaplan–Meier curves and Cox proportional-hazards models were also performed. Results: A total of 3265 patients included, with 36.7% women. Women had an increased risk of ≥ 2 exacerbations (aOR=1.79; 95%CI[1.46– 2.19]), mMRC grade 1 (aOR=1.46; 95%CI[1.14– 1.89]) and grade 2 (aOR=1.41; 95%CI[1.07– 1.87]) and a higher risk of severity E of the ABE classification (aOR=1.56; 95%CI[1.27– 1.93]). In stratified models, the determinants of these outcomes were different. Men had a lower survival rate at GOLD airway obstruction I–II (Log-rank: p< 0.0001) and III–IV (Log-rank: p< 0.0001) and a higher risk of mortality (HR=1.62; 95%CI[1.40– 1.87]). Common factors characterizing mortality were: age, BMI < 18.5, mMRC ≥ 2, airway obstruction, diabetes and lung cancer. Additional factors related to mortality in men were asthma, left heart failure and tobacco-related cancers. Conclusion: COPD is more severe in women however men have a higher risk of mortality. Clinical features and mortality in men and women with COPD are different in our cohort. Further studies are needed to elucidate sex-related differences among COPD patients.
- 1 March 2026
- Published by Taylor & Francis in International Journal of Chronic Obstructive Pulmonary Disease
- Vol. ume 21, 1-13
Open AccessSex Differences and Survival Among COPD Patients in France: The Palomb Cohort
Purpose: Previous studies suggest that the clinical presentation of chronic obstructive pulmonary disease (COPD) is different between men and women. The aim of this study was to investigate sex-related differences and survival among COPD patients. Patients and Methods: Multicentric prospective real-life cohort. COPD patients (post-bronchodilator FEV1/FVC < 0.7) of any stages of airway obstruction recruited since January 2014 by pulmonologists. Stratified logistic regression models assessed to identify the determinants of dyspnea, exacerbations, ABE classification and all-cause mortality by sex. Kaplan–Meier curves and Cox proportional-hazards models were also performed. Results: A total of 3265 patients included, with 36.7% women. Women had an increased risk of ≥ 2 exacerbations (aOR=1.79; 95%CI[1.46– 2.19]), mMRC grade 1 (aOR=1.46; 95%CI[1.14– 1.89]) and grade 2 (aOR=1.41; 95%CI[1.07– 1.87]) and a higher risk of severity E of the ABE classification (aOR=1.56; 95%CI[1.27– 1.93]). In stratified models, the determinants of these outcomes were different. Men had a lower survival rate at GOLD airway obstruction I–II (Log-rank: p< 0.0001) and III–IV (Log-rank: p< 0.0001) and a higher risk of mortality (HR=1.62; 95%CI[1.40– 1.87]). Common factors characterizing mortality were: age, BMI < 18.5, mMRC ≥ 2, airway obstruction, diabetes and lung cancer. Additional factors related to mortality in men were asthma, left heart failure and tobacco-related cancers. Conclusion: COPD is more severe in women however men have a higher risk of mortality. Clinical features and mortality in men and women with COPD are different in our cohort. Further studies are needed to elucidate sex-related differences among COPD patients.
- 7 July 2023
- Published by Elsevier in Revue des Maladies Respiratoires Actualités
- Vol. 15 (1) , 1S6-1S11
L’asthme et l’allergie, rencontres de type 2
- 7 July 2023
- Published by Elsevier in Revue des Maladies Respiratoires Actualités
- Vol. 15 (1) , 1S6-1S11
L’asthme et l’allergie, rencontres de type 2
- 1 April 2016
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 56 (3) , 194-195
Asthme et grossesse
- 1 April 2016
- Published by Elsevier in Revue Française d'Allergologie
- Vol. 56 (3) , 194-195
Asthme et grossesse